ASH 2017: Dr. Jennifer Brown on Bleeding Problems with Ibrutinib in CLL (chronic lymphocytic leukemia) At ASH 2017, Dr. Jennifer Brown, the Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber... May 22, 20182017 ConferencesBy Todd Dennison
ASH 2017: Dr. Dearden on the Progress and Remaining Unmet Needs in CLL (chronic lymphocytic leukemia) At ASH (American Society of Hematology Annual Meeting) in Dec. 2017 in Atlanta, Georgia, I re-interviewed one of the nicest... May 15, 20182017 ConferencesBy Todd Dennison
ASH 2017: Dr. Tam on the Prognostic Value of IVGH mutation status in CLL (chronic lymphocytic leukemia) Dr. Constantine Tam of Peter MacCallum Cancer Center, Melbourne, Australia has contributed important research for chronic lymphocytic leukemia patients while... May 7, 20182017 ConferencesBy Brian Koffman
ASH 2017: Dr. Matthew Davids on Umbralisib (TGR-1202) for chronic lymphocytic leukemia (CLL) At ASH 2017, I interviewed Dr. Matthew Davids on a new PI3K∆ inhibitor, umbralisib (formerly TGR-1202) for treating CLL. We know... May 1, 20182017 ConferencesBy Todd Dennison
ASH 2017: Dr. Jennifer Brown Discusses the Association Between Idelalisib and Liver Inflammation in CLL At the 2017 ASH Annual Meeting, Dr. Brian Koffman interviewed Dr. Jennifer Brown from Dana Farber Cancer Institute at Harvard... April 24, 20182017 ConferencesBy Todd Dennison
ASH 2017: Dr. Follows Discusses the MURANO Trial (Venetoclax and Rituximab) in Chronic Lymphocytic Leukemia (CLL) At the 2017 ASH Annual Meeting in Atlanta, GA, Dr. Brian Koffman interviewed Dr. George Follows from the Cambridge University... April 14, 20182017 ConferencesBy Brian Koffman
ASH 2017: Dr. Choi Discusses the Potential of Non-Chemotherapy Regimens for the Treatment of Chronic Lymphocytic Leukemia (CLL) At the 2017 ASH Annual Meeting in Atlanta, GA, Dr. Brian Koffman interviewed Dr. Michael Choi from the University of... April 10, 20182017 ConferencesBy Todd Dennison
ASH 2017: Dr. Mato on PET Scans Identifying Richter’s Transformation in CLL (chronic lymphocytic leukemia) By Brian Koffman, MD and Anthony Mato, MD As we are getting better at controlling CLL and living longer, there... March 28, 20182017 ConferencesBy clladm1n
ASH 2017: Dr. Con Tam on BGB-3111 or Zanubrutinib for Chronic Lymphocytic Leukemia (CLL) Dr. Constantine Tam from Peter McCallum in Melbourne Australia has led pioneering research on important new drugs to treat chronic... March 13, 20182017 ConferencesBy Todd Dennison
Dr. Forconi on the Benefits of Combining Venetoclax and Ibrutinib in Treating Chronic Lymphocytic Leukemia (CLL) Dr. Francesco Forconi of the University Of Southampton in the UK has a deep understanding of the nature of CLL... March 6, 20182017 ConferencesBy Todd Dennison
